Molecular characterization of type 3 (neuronopathic) Gaucher disease in Thai patients. Suwannarat P, Keeratichamroen S, Wattanasirichaigoon D*, Ngiwsara L, Cairns JR, Svasti J, Visudtibhan A, Pangkanon S. Blood Cells Mol Dis. 2007 Nov-Dec;39(3):348-52.

01 Nov 2007
0
0

Molecular characterization of type 3 (neuronopathic) Gaucher disease in Thai patients.

Suwannarat P, Keeratichamroen S, Wattanasirichaigoon D*, Ngiwsara L, Cairns JR, Svasti J, Visudtibhan A, Pangkanon S.

Blood Cells Mol Dis. 2007 Nov-Dec;39(3):348-52.

Tags

Share this

Related Posts

Tangdenpaisal, K; Chuayboonsong, K; Ruchirawat, S; Ploypradith, P. Divergent Strategy for the Diastereoselective Synthesis of the Tricyclic 6,7-Diaryltetrahydro-6H-benzo[c]chromene Core via Pt(IV)-Catalyzed Cycloaddition of o-Quinone Methides and Olefin Ring-Closing Metathesis. J. Org. Chem. 2017, 82, 2672−2688.
28 Dec 2017
0

Tangdenpaisal, K; Chuayboonsong, K; Ruchirawat, S; Ploypradith, P. Divergent Strategy for the Diastereoselective Synthesis of the Tricyclic 6,7-Diaryltetrahydro-6H-benzo[c]chromene Core via Pt(IV)-Catalyzed Cycloaddition of o-Quinone Methides and Olefin Ring-Closing Metathesis. J. Org. Chem. 2017, 82, 2672−2688.

Tangdenpaisal, K; Chuayboonsong, K; Ruchirawat, S; Ploypradith, P. Divergent Strategy for the Diastereoselective Synthesis of the Tricyclic 6,7-Diaryltetrahydro-6H-benzo[c]chromene Core via Pt(IV)-Catalyzed Cycloaddition of o-Quinone Methides and Olefin Ring-Closing Metathesis. J. Org. Chem. 2017, 82, 2672−2688.
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
New
20 Sep 2023
0
New

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More